- Country: Belgium
- Summary: Antineoplastica (Atc L01) En Andere Immunosuppressiva (Atc L04ax)
- BET Ref No: 116485718
- Deadline: 07 Apr 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 179858-2025
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Antinoplastica (ATC L01) and other immunosuppressants (ATC L04AX)
Methotrexate 50mg/ml (injectable)
azacitidine 25mg/ml (injectable)
Capecitabine (oral)
Irinotecan 1mg/ml (injectable) (injectable)
Etoposide 20mg/ml (injectable)
Sorafenib 200mg (oral)
Doxorubicinliposomaal 2mg/mL (injecteerbaar)
Doc Title: Antineoplastica (ATC L01) en andere immunosuppressiva (ATC L04AX)
Contract Type: supplies - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINAntineoplastica (Atc L01) En Andere Immunosuppressiva (Atc L04ax) - Belgium Tender
The HEALTHCARE PUBLIC PROCUREMENT (HECAPP), a Government sector organization in Belgium, has announced a new tender for Antineoplastica (Atc L01) En Andere Immunosuppressiva (Atc L04ax). This tender is published on BelgiumTenders under BET Ref No: 116485718 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-04-07.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
